Digital Twins Could Revolutionize Medication Evaluation, But Validation Challenges Persist

Digital twins of human organs and tissues may enable more accurate and efficient medication testing, but technical hurdles must be overcome.

Researchers are exploring the use of digital twins to simulate the behavior of human organs and tissues in response to different medications. This could enable more accurate and efficient testing of new treatments, reducing the need for animal testing and minimizing the risk of human clinical trials. However, the development of reliable digital twins requires significant advances in data quality and modeling techniques.